Prevalence and Incidence of Pressure Injuries in Palliative Care Settings: A Systematic Review Update
International Journal of Wound Research · 2026-09-26 · 2 (3) · 199-210
DOI: 10.64115/411bn337 ↗Abstract
Introduction. Pressure injuries (PIs) are a frequent complication among patients receiving palliative and end-of-life (EoL) care. However, epidemiological estimates vary widely across clinical settings, and the understanding of pressure-related skin damage in palliative populations has evolved considerably in recent years. This systematic review aimed to update the evidence on the prevalence, incidence, and risk factors associated with PIs in palliative care settings. Methods. A systematic review was conducted according to the PRISMA 2020 guidelines. PubMed/MEDLINE, CINAHL, Embase, and Scopus were searched to identify studies reporting the prevalence and/or incidence of PIs in palliative care or EoL care settings. Eligibility criteria were defined using the CoCoPop framework. Risk of bias was assessed using design-specific critical appraisal tools, and results were synthesised narratively. Results. The search identified 443 records, of which eight studies met the inclusion criteria. Studies were conducted across multiple palliative care settings, including home care services, hospice facilities, and hospital-based palliative care units. Reported PI prevalence ranged from 9.0% to 34.1%, while incidence ranged from 3.9% to 26.5%. Most lesions were stage 1 or 2 and commonly located in the sacral region. Identified risk factors included advanced age, reduced mobility, impaired nutritional status, comorbidities, and the presence of medical devices such as urinary catheters. Discussion. PIs remain a common complication in palliative and EoL care populations. Their development reflects the multifactorial interaction between clinical deterioration, functional decline, and skin failure. Preventive strategies should therefore be integrated with comfort-focused care and careful clinical assessment, recognising that some PIs may be unavoidable in patients approaching the EoL.
EUVIMED